HHS Secretary nominee Robert F. Kennedy Jr. will divest his interests in several biopharma companies, including CRISPR ...

Thermo Fisher Scientific should be safe. RFK Jr. may disrupt Big Pharma, but he’s unlikely to cause research to completely ...

Don Dempsey reportedly in frame to serve as Office of Management and Budget’s leading health offical, a role that would hand him sweeping powers to rein in Kennedy’s ambitions ...

Documents show Robert F. Kennedy Jr. invested in biotech companies and consulted on health care — interests he might have to ...

Editorial page editor Jim Dao sits down with Globe Opinion columnist Joan Vennochi and Globe political reporter James Pindell ...

Sen. John Fetterman is scaring liberals by cozying up to President-elect Trump. He’s acting like the wildcard successor to ...

Plus: A stomach flu vaccine, the health impacts of California’s wildfires, lots of nine-figure deals for healthcare startups ...

Inside details from the autopsy of Robert F. Kennedy could unveil the chilling truth behind the U.S. senator‘s violent death.

So the first thing I would just say is: RFK is who he’s always been ... I am now going to use “facts maxer” as part of my bio. Demsas: That would work. Bedard: It would do it, right?

“RFK Jr. also said yesterday that he ... healthier through more nutritious diets and more active lifestyles. Her biography on President Barack Obama’s presidential library site also notes ...

Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...